公司概覽
業務類別 Diagnostics & Research
業務概覽 Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
公司地址 77 4th Avenue, Waltham, MA, USA, 02451
電話號碼 +1 781 663-6900
傳真號碼 --
公司網頁 https://www.revvity.com
員工數量 11000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Joel S. Goldberg Senior Vice President, Administration, General Counsel and Secretary 美元 564.62K 24/02/2026
Mr. Tajinder S. Vohra Senior Vice President, Global Operations 美元 489.62K 24/02/2026
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer 美元 1.13M 16/03/2026
Ms. Miriame Victor Senior Vice President and Chief Commercial Officer 美元 503.27K 24/02/2026
Ms. Anita Gonzales Vice President and Chief Accounting Officer -- 24/02/2026
Mr. Maxwell Krakowiak Senior Vice President and Chief Financial Officer 美元 550.58K 24/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Michael A Klobuchar Independent Director 16/03/2026
Dr. Sophie V. Vandebroek, PhD Independent Director 16/03/2026
Dr. Peter Barrett,PhD Independent Director 16/03/2026
Mr. Alexis P. Michas Non-Executive Chairman of the Board 16/03/2026
Dr. Frank R. Witney,, PhD Independent Director 16/03/2026
Ms. Pascale Witz, M. Sc.,M.B.A. Independent Director 16/03/2026
Mr. Michel Pericles Vounatsos Independent Director 16/03/2026
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer 16/03/2026
Mr. Samuel R. Chapin Independent Director 16/03/2026
Dr. Michelle McMurry-Heath, M.D.,PhD Independent Director 16/03/2026
 
所屬ETF (更新日期: 02/05/2026 03:26)
代號 名稱 佔比% 持有日期
AAEQAlpha Architect US Equity 2 ETF<0.000001%30/03/2026
AAUSAlpha Architect US Equity ETF<0.000001%05/12/2025
ACWIiShares MSCI ACWI ETF<0.000001%04/03/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
AVUSAvantis US Equity ETF<0.000001%04/03/2026
BBUSJPMorgan BetaBuilders US Equity ETF<0.000001%22/12/2025
BDVLiShares Disciplined Vol Eq Act ETF<0.000001%08/10/2025
BKLCBNY Mellon US Large Cap Core Equity ETF<0.000001%07/08/2025
BULPacer US Cash Cows Growth ETF<0.000001%05/03/2026
CFAVictoryShares US 500 Volatility Wtd ETF<0.000001%22/09/2025
CFOVictoryShares US 500 Enh Vol Wtd ETF<0.000001%22/09/2025
CGUSCapital Group Core Equity ETF<0.000001%31/08/2025
CLSEConvergence Long/Short Equity ETF<0.000001%10/12/2025
CNBSAmplify Seymour Cannabis ETF<0.000001%05/03/2026
CRBNiShares Low Carbon Optd MSCI ACWI ETF<0.000001%06/03/2026
DFLVDimensional US Large Cap Value ETF<0.000001%25/08/2025
DWSHAdvisorShares Dorsey Wright Short ETF<0.000001%05/12/2025
EEECyber Hornet S&P 500®AndEth75/25StrETF<0.000001%29/04/2026
EPSWisdomTree U.S. LargeCap Fund<0.000001%11/12/2025
ESGFlexShares STOXX US ESG Select ETF<0.000001%22/09/2025
  1    2    3    4    5    6    7    8   9    10    11    12  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.